# Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.

> **NCT03191162** · PHASE2 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 238 (actual)

## Conditions studied

- Chagas Disease
- Trypanosoma Cruzi Infection

## Interventions

- **DRUG:** Benznidazole

## Key facts

- **NCT ID:** NCT03191162
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-21
- **Primary completion:** 2020-09-21
- **Final completion:** 2021-03-16
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03191162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03191162, "Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03191162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*